Table 1.
Characteristics of patient and donor.
| Characteristics | N=80 |
|---|---|
| Median age, year (range) | 28 (14-56) |
| Gender, n (%) | |
| Male | 42 (52.50) |
| Female | 38 (47.50) |
| Disease, n (%) | |
| AML | 37 (46.25) |
| ALL | 38 (47.50) |
| MDS | 5 (6.25) |
| Risk stratification, n (%) | |
| AML/MDS | |
| Intermediate | 18 (42.86) |
| High | 24 (57.14) |
| ALL | |
| Standard | 14 (36.84) |
| High | 24 (63.16) |
| Median time from diagnosis to HSCT, months (range) | 6.0 (0.3-36.0) |
| Median follow-up time, months (range) | 22.4 (2.5-57.8) |
| Disease status, n (%) | |
| AML/MDS | |
| CR1 | 26 (61.90) |
| CR≥2 | 13 (30.95) |
| Non-CR | 3 (7.15) |
| ALL | |
| CR1 | 23 (60.53) |
| CR≥2 | 14 (36.84) |
| Non-CR | 1 (2.63) |
| MRD | |
| Negative | 73 (96.25) |
| Positive | 7 (3.75) |
| Donor-recipient sex match, n (%) | |
| Male-male | 29 (36.25) |
| Male-female | 26 (32.50) |
| Female-male | 16 (20.00) |
| Female-female | 9 (11.25) |
| Donor-recipient blood match, n (%) | |
| Matched | 53 (66.25) |
| Major mismatched | 13 (16.25) |
| Minor mismatched | 14 (17.50) |
| HLA compatibility of, n (%) | |
| PB | |
| 5/10 | 45 (56.25) |
| 6/10 | 23 (28.75) |
| 7/10 | 5 (6.25) |
| 8/10 | 5 (6.25) |
| 9/10 | 2 (2.50) |
| UCB | |
| 6/10 | 7 (8.75) |
| 7/10 | 17 (21.25) |
| 8/10 | 32 (41.25) |
| 9/10 | 19 (23.75) |
| 10/10 | 4 (5.00) |
| Median PB MNC, ×108/kg (range) | 10.50 (4.63-19.30) |
| Median PB CD34+ cells, ×10 6/kg (range) | 5.68 (1.61-14.12) |
| UCB MNC, ×10 7/kg | 1 |
| UCB CD34+ cells, ×10 4/kg | 3.42 (1.12-13.56) |
AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; MDS, myelodysplastic syndrome; HSCT, hemopoietic stem cell transplantation; CR, complete remission; PB, peripheral blood; UCB, unrelated cord-blood.